ArticleCurrent microbiology2025
Purification and Immobilization of Burkholderia gladioli Cholesterol Oxidase on Calcium Alginate, with Robust Catalytic Stability for Cholesterol Oxidation In Vitro.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Cholesterol oxidase (COX) is a key enzyme in diagnostic kits of cardiovascular diseases via oxidation of cholesterol producing smart enantiomerically compounds; however, the enzyme catalytic stability is the challenge. So, the objective of this study was to purify COX from novel endophytic bacterial isolates of medicinal plants that could have unique catalytic efficiency for the desired applications. Among the recovered forty bacterial isolates, Burkholderia gladioli EFBL PQ721377, an endophyte of Eruca sativa, had the highest COX productivity (14.7 μmol/mg/min). The COX productivity of B. gladioli has been maximized by with the response surface methodology, giving the highest productivity 30.9 μmol/mg/min, by ~ 2.0-fold increment compared to control. The enzyme was purified to its molecular homogeneity with subunit structure 40 kDa. The enzyme was entrapped in Ca-alginate with immobilization yield 87.5%, and the efficiency and homogeneity in Ca-alginate beads were assessed by FTIR and SEM-EDX analyses. The free and Ca-alginate-COX conjugates have the same maximum reaction temperature at 37-40 °C, reaction pH at 7.5 and pH stability at 6.5-8.0. The thermal stability of Ca-alginate-COX was increased by ~ 7.0 folds compared to the free one, ensuring the protective role of alginate beads on enzyme tertiary structure. Ca-alginate-COX had a higher potency of oxidation of human serum cholesterol, than the free one, confirming the feasibility of the product release, and allosteric activation of the enzyme, with a reliable operative stability till the fifth cycle, for production of cholest-4-en-3-one, as the precursor of various drugs.
Indexed as
Identifiers
39909895What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.